triamterene and hydrochlorothiazide (50090-1270)

Drug Facts

Product Profile

Brand Name triamterene and hydrochlorothiazide

Generic Name triamterene and hydrochlorothiazide

Labeler a-s medication solutions

Dosage Form TABLET

Routes

ORAL

Active Ingredients

hydrochlorothiazide 25 mg/1, triamterene 37.5 mg/1

Manufacturer

A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-1270

Product ID 50090-1270_2b8f9bb4-9da2-4267-abc3-c2b76bf6d521

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA073449

Marketing Start 1993-09-23

Marketing End 2028-06-30

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc] potassium-sparing diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe] decreased renal k+ excretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500901270

Hyphenated Format 50090-1270

Supplemental Identifiers

RxCUI

310812

UNII

0J48LPH2TH WS821Z52LQ

NUI

N0000175359 N0000175419 M0471776 N0000008859 N0000175418

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name triamterene and hydrochlorothiazide (source: ndc)

Generic Name triamterene and hydrochlorothiazide (source: ndc)

Application Number ANDA073449 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
37.5 mg/1

source: ndc

Packaging

30 TABLET in 1 BOTTLE (50090-1270-0)
100 TABLET in 1 BOTTLE (50090-1270-1)
90 TABLET in 1 BOTTLE (50090-1270-2)

source: ndc

Packages (3)

50090-1270-0 30 TABLET in 1 BOTTLE (50090-1270-0) 50090-1270-1 100 TABLET in 1 BOTTLE (50090-1270-1) 50090-1270-2 90 TABLET in 1 BOTTLE (50090-1270-2)

Ingredients (2)

hydrochlorothiazide (25 mg/1) triamterene (37.5 mg/1)

Linked Drug Pages (1)

Triamterene and Hydrochlorothiazide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "2b8f9bb4-9da2-4267-abc3-c2b76bf6d521", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000008859", "N0000175418"], "unii": ["0J48LPH2TH", "WS821Z52LQ"], "rxcui": ["310812"], "spl_set_id": ["f4f026f9-5f21-435e-8878-01dc9bbe2d66"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]", "Decreased Renal K+ Excretion [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Potassium-sparing Diuretic [EPC]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-1270-0)", "package_ndc": "50090-1270-0", "marketing_end_date": "20280630", "marketing_start_date": "20141128"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (50090-1270-1)", "package_ndc": "50090-1270-1", "marketing_end_date": "20280630", "marketing_start_date": "20141128"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-1270-2)", "package_ndc": "50090-1270-2", "marketing_end_date": "20280630", "marketing_start_date": "20141128"}], "brand_name": "Triamterene and Hydrochlorothiazide", "product_id": "50090-1270_2b8f9bb4-9da2-4267-abc3-c2b76bf6d521", "dosage_form": "TABLET", "pharm_class": ["Decreased Renal K+ Excretion [PE]", "Increased Diuresis [PE]", "Increased Diuresis [PE]", "Potassium-sparing Diuretic [EPC]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "50090-1270", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triamterene and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "TRIAMTERENE", "strength": "37.5 mg/1"}], "application_number": "ANDA073449", "marketing_category": "ANDA", "marketing_end_date": "20280630", "marketing_start_date": "19930923"}